Supportive Care | Specialty

Clinical Trial Results of MM-398 in Pancreatic Cancer

February 15th 2016

Dose Modification Rationale in Advanced Pancreatic Cancer

February 15th 2016

Deciding Among Frontline Standards of Care in Pancreatic Cancer

February 15th 2016

Systemic Therapy in Newly Diagnosed Pancreatic Cancer

February 15th 2016

Bankruptcy in Cancer Survivors

February 13th 2016

Matthew Banegas, PhD, MPH, discusses a recent study that found that a considerable number of working-age adults who survive cancer and its toxic treatments, end up with substantial medical debts or declare bankruptcy.

FDA Approves Single-Dose Fosaprepitant for CINV

February 4th 2016

The FDA approved single-dose fosaprepitant dimeglumine (Emend for injection) in combination with other antiemetic agents for the prevention of delayed chemotherapy-induced nausea and vomiting (CINV) following moderately emetogenic chemotherapy (MEC), according to Merck, the developer of the drug.

Radium-223 Benefits Survival, Not Just for Palliative Care

January 25th 2016

Phillip J. Koo, MD, discusses the benefits of radium-223 and why he thinks it is time the use of the drug becomes more widespread for the treatment of mCRPC, and potentially other cancers.

Delayed Decision on CINV Therapy, Priority Review in RCC, and CSS Highlights

January 21st 2016

Strong Evidence for Palliative Care Intervention But Adoption Is Slow

January 4th 2016

As more studies link aggressive end-of-life oncology care to problems such as suboptimal cost and quality outcomes, experts are increasingly proposing earlier, more comprehensive palliative care interventions.

Prophylactic Intervention Improves Cardiac Safety in HER2-Positive Breast Cancer

December 10th 2015

Prophylactic administration of standard heart failure medications helped preserve left ventricular ejection fraction in patients treated with trastuzumab for HER2-positive metastatic breast cancer.

Holland's Quest to Help Patients Cope With Cancer Launched a New Field

December 9th 2015

Jimmie C. Holland, MD, whose emphasis on patients’ psychosocial needs helped humanize cancer care, was honored in the Supportive Care category with a 2014 Giants of Cancer Care® award, a program that the Intellisphere® Oncology Specialty Group launched to honor leaders in the field.

Dr. Brian Baumann on the Impact of Skin Cream Use Prior to Radiation

December 8th 2015

Brian Baumann, MD, medical oncologist, University of Pennsylvania, discusses the impact of skin creams on radiation.

Dr. Lawrence Fong on Managing the Side Effects of Immunotherapies

December 7th 2015

Lawrence Fong, MD, Professor, Department of Medicine (Hematology/Oncology), University of California San Francisco, discusses the importance of educating oncologists on the side effects of immunotherapies.

New Model Supports Use of Palliative Care With Radiotherapy for Bone Metastases

December 4th 2015

A novel service model that incorporated palliative care measures and shorter radiation treatment was associated with fewer unfinished treatments with radiation, shorter hospital stays, and increased use of palliative care for patients with bone metastases.

ASCO, AAHPM Craft Guidance Statement for Palliative Care

December 3rd 2015

ASCO and AAHPM recently partnered to create a consensus definition of high-quality palliative care.

June Provides Insight Into Managing AEs From CAR T-Cell Therapies

November 21st 2015

Though clinical work is ongoing and early, researchers are already considering how to manage potentially fatal neurotoxicities in patients treated with chimeric antigen receptor T-cell therapy

Testing Checkpoint Inhibitors in Brain Cancer Requires Careful AE Management

November 20th 2015

As immunotherapy begins to be studied across central nervous system tumors it becomes increasingly important for practitioners to understanding the unique adverse event profiles associated with these agents.

Novel Drug Relieves Carcinoid Syndrome Symptoms

October 16th 2015

Telotristat etiprate, a novel serotonin synthesis inhibitor, helped reduce daily bowel movements for patients with carcinoid syndrome no longer responding to standard-of-care therapies.

Dr. Poortmans on Impact of Multidisciplinary Approach on Side Effect Management

October 7th 2015

Philip Poortmans, MD, PhD, head of Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands, and president of European Society for Therapeutic Radiology and Oncology, discusses the impact of a multidisciplinary approach on survivorship and side effect management for patients with prostate cancer.

Jeanine Stiles on the Importance of Supportive Care for Patients With Cancer

September 22nd 2015

Jeanine Stiles, chief administrative officer, associate director for administration, UC Davis Comprehensive Cancer Center, discusses the importance of supportive care for patients with cancer.